129 related articles for article (PubMed ID: 2298911)
1. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
Voeller D; Kovacs J; Andrawis V; Chu E; Masur H; Allegra C
J Infect Dis; 1994 Feb; 169(2):456-9. PubMed ID: 8106784
[TBL] [Abstract][Full Text] [Related]
3. Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.
Chio LC; Bolyard LA; Nasr M; Queener SF
Antimicrob Agents Chemother; 1996 Mar; 40(3):727-33. PubMed ID: 8851601
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity of sulfones and sulfonamides on dihydropteroate synthetase from Neisseria meingitidis.
Ho RI; Corman L; Mores SA; Schneider H
Antimicrob Agents Chemother; 1975 Jun; 7(6):758-63. PubMed ID: 808157
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: characterization of a mutant resistant to sulfonamides.
Pfefferkorn ER; Borotz SE; Nothnagel RF
Exp Parasitol; 1992 May; 74(3):261-70. PubMed ID: 1582478
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationships in dihydropteroate synthase inhibition by multisubstituted sulfones. Design and synthesis of some new derivatives with improved potency.
De Benedetti PG; Iarossi D; Folli U; Frassineti C; Menziani MC; Cennamo C
J Med Chem; 1989 Oct; 32(10):2396-9. PubMed ID: 2677378
[TBL] [Abstract][Full Text] [Related]
7. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.
Lever OW; Bell LN; McGuire HM; Ferone R
J Med Chem; 1985 Dec; 28(12):1870-4. PubMed ID: 3906132
[TBL] [Abstract][Full Text] [Related]
8. Comparative QSAR analysis in dihydropteroate synthase inhibition by sulphones. Design and synthesis of some new derivatives with improved potency.
De Benedetti PG; Iarossi D; Frassineti C; Menziani MC; Cocchi M; Cennamo C
Prog Clin Biol Res; 1989; 291():345-8. PubMed ID: 2726870
[No Abstract] [Full Text] [Related]
9. Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Merali S; Zhang Y; Sloan D; Meshnick S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1075-8. PubMed ID: 2203302
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity analysis in dihydropteroate synthase inhibition by sulfones. Comparison with sulfanilamides.
De Benedetti PG; Iarossi D; Menziani C; Caiolfa V; Frassineti C; Cennamo C
J Med Chem; 1987 Mar; 30(3):459-64. PubMed ID: 3546688
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis.
Aspinall TV; Joynson DH; Guy E; Hyde JE; Sims PF
J Infect Dis; 2002 Jun; 185(11):1637-43. PubMed ID: 12023770
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.
Lever OW; Bell LN; Hyman C; McGuire HM; Ferone R
J Med Chem; 1986 May; 29(5):665-70. PubMed ID: 3486292
[TBL] [Abstract][Full Text] [Related]
13. The effect of mafenide on dihydropteroate synthase.
Eagon RG; McManus AT
J Antimicrob Chemother; 1990 Jan; 25(1):25-9. PubMed ID: 2108114
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.
McCullough JL; Maren TH
Antimicrob Agents Chemother; 1973 Jun; 3(6):665-9. PubMed ID: 4597736
[TBL] [Abstract][Full Text] [Related]
16. Arabidopsis dihydropteroate synthase: general properties and inhibition by reaction product and sulfonamides.
Prabhu V; Lui H; King J
Phytochemistry; 1997 May; 45(1):23-7. PubMed ID: 9127492
[TBL] [Abstract][Full Text] [Related]
17. Identification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductase.
Chio LC; Queener SF
Antimicrob Agents Chemother; 1993 Sep; 37(9):1914-23. PubMed ID: 8239605
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs.
Zhang Y; Meshnick SR
Antimicrob Agents Chemother; 1991 Feb; 35(2):267-71. PubMed ID: 2024960
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Hong YL; Hossler PA; Calhoun DH; Meshnick SR
Antimicrob Agents Chemother; 1995 Aug; 39(8):1756-63. PubMed ID: 7486915
[TBL] [Abstract][Full Text] [Related]
20. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
Das BK; Pv P; Chakraborty D
Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
